UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 17, 2022
Accession Number:
0001193125-22-286762
Submission Type:
POS AM
CIK:
0001696396
Company Name:
Stealth BioTherapeutics Corp
File Number:
333-239356